Company / R&D per Share
Voyager Therapeutics, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.68
FY2025
5-year range
$1.38 / $3.20
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share returned to growth in FY2025 after 3 years of decline, reaching $1.68.
Based on SEC 10-K filings.
1.68 in FY2025 with a 5-year CAGR of -0.9%.
Declined from $1.91 to $1.68 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -16.3%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 22.1% year-over-year.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.68 | +22.1% |
| FY2024 | $1.38 | -27.8% |
| FY2023 | $1.91 | -33.4% |
| FY2022 | $2.87 | -10.5% |
| FY2021 | $3.20 | +82.0% |
| FY2020 | $1.76 | -8.5% |
| FY2019 | $1.92 | +43.8% |
| FY2018 | $1.34 | +23.8% |
| FY2017 | $1.08 | +203.0% |
| FY2016 | $0.36 | -87.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026